What is CV (CV) stock price today?

CV (CV) is currently trading at $6.63, up 0.15% today.

What is CV P/E ratio?

CV's P/E ratio is -6.45. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CV return on equity (ROE)?

CV's return on equity (ROE) is -192.31%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is CV's market cap?

CV has a market capitalization of $331.26M.

NASDAQ · Medical - Equipment & Services

CV (CV) Stock

$6.63 +0.15% NASDAQ: CV Healthcare

Valuation

Metric	Value
Price	$6.63
Market Cap	$331.26M
P/E Ratio	-6.45
P/B Ratio	25.52
P/S Ratio	24.46
EPS (TTM)	$0.00
52-Week High	$15.37
52-Week Low	$3.43
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-192.31%
ROA	-138.89%
ROCE	0.00%
Gross Margin	7.14%
Operating Margin	0.00%
Net Margin	-1.99%
Debt/Equity	0.04
Current Ratio	4.25

Annual Financials (USD)

Metric	2023	2024	2025
Revenue	$10.0M	$12.0M	$14.0M
Operating Profit	$-11.0M	$-20.0M	$0
Net Profit	$-11.0M	$-20.0M	$-25.0M
EPS	$-0.29	$-0.52	$-1.03
Op Margin	-116.3%	-169.4%	1.7%

Balance Sheet (USD)

Metric	2023	2024	2025
Total Assets	$22.0M	$17.0M	$18.0M
Total Liabilities	$131.0M	$146.0M	$5.0M
Cash	$15.0M	$9.0M	$10.0M
Borrowings	$2.0M	$1.0M	$1.0M

Latest News

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors GlobeNewswire · Jul 2, 2026 CapsoVision Q1 Earnings Call Highlights MarketBeat · May 14, 2026 CapsoVision Reports First Quarter 2026 Financial Results GlobeNewswire · May 14, 2026 CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 GlobeNewswire · Apr 30, 2026 CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership Simply Wall St. · Apr 24, 2026

Cash Flow (USD)

Metric	2023	2024	2025
Operating Cash Flow	$-11.0M	$-20.0M	$-23.0M
Investing Cash Flow	$-2.0M	$0	$0
Financing Cash Flow	$0	$0	$-3.0M
Net Cash Flow	$9.0M	$-5.0M	$1.0M
Free Cash Flow	$-12.0M	$-20.0M	$-23.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-8.76%
Quick Ratio	3.92
Interest Coverage	—
Return 1Y	55.29%
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held32.09%

Institutions Held8.14%

Institutions Float Held11.99%

Institutional Holder	Shares	Report Date
Blackrock Inc.	1,304,421	2026-03-31
Vanguard Capital Management LLC	1,026,269	2026-03-31
Geode Capital Management, LLC	435,154	2026-03-31
State Street Corporation	256,041	2026-03-31
Vanguard Portfolio Management LLC	164,386	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About CV

CV is led by CEO Kang-Huai Wang, employs 90 people, headquartered in US, publicly traded since 2001.

CV stock trades at $6.63 with a market capitalization of $331.26M. The stock is valued at a price-to-earnings (P/E) ratio of -6.45, price-to-book of 25.52, price-to-sales of 24.46. Over the past 52 weeks the stock has ranged between $3.43 and $15.37, and currently trades 56.9% below its 52-week high.

On profitability, CV generates a return on equity (ROE) of -192.31%, return on capital employed of 0.00%, an operating margin of 0.00%, a net profit margin of -1.99%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides